(Q48181141)

9 February 2018

title

Preliminary evaluation of clinical outcome and safety of ketamine as an anesthetic for electroconvulsive therapy in schizophrenia (English)

1 reference

9 February 2018

0 references

4

1 reference

9 February 2018

author name string

Laura Kranaster

series ordinal

1

1 reference

9 February 2018

Carolin Hoyer

series ordinal

2

1 reference

9 February 2018

Christoph Janke

series ordinal

3

1 reference

9 February 2018

publication date

8 March 2012

1 reference

9 February 2018

World Journal of Biological Psychiatry

published in

1 reference

9 February 2018

volume

15

1 reference

9 February 2018

issue

3

1 reference

9 February 2018

page(s)

242-250

1 reference

9 February 2018

General anesthesia and the neural correlates of consciousness

cites work

1 reference

https://api.crossref.org/works/10.3109%2F15622975.2011.647833

Ketamine reduces the cell death following inflammatory pain in newborn rat brain

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F15622975.2011.647833

Ketamine (“Ketalar”): A Safer Anaesthetic for ECT

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F15622975.2011.647833

Influence of anesthetic drugs and concurrent psychiatric medication on seizure adequacy during electroconvulsive therapy.

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F15622975.2011.647833

Managing cognitive dysfunction through the continuum of Alzheimer's disease: role of pharmacotherapy

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F15622975.2011.647833

Anesthesia for electroconvulsive therapy

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F15622975.2011.647833

PHARMACOLOGIC EFFECTS OF CI-581, A NEW DISSOCIATIVE ANESTHETIC, IN MAN.

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F15622975.2011.647833

A naturalistic study of the measurement of seizure adequacy in electroconvulsive therapy.

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F15622975.2011.647833

Convulsive therapy in schizophrenia?

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F15622975.2011.647833

Neonatal exposure to a combination of N-methyl-D-aspartate and gamma-aminobutyric acid type A receptor anesthetic agents potentiates apoptotic neurodegeneration and persistent behavioral deficits

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F15622975.2011.647833

Acute administration of ketamine induces antidepressant-like effects in the forced swimming test and increases BDNF levels in the rat hippocampus

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F15622975.2011.647833

Dose- and exposure-response to ketamine in depression

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F15622975.2011.647833

Ketamine As an Anaesthetic for Ect

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F15622975.2011.647833

Ketamine and neurotoxicity: clinical perspectives and implications for emergency medicine

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F15622975.2011.647833

The acute effects of NMDA antagonism: from the rodent to the human brain

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F15622975.2011.647833

Repeated administration of ketamine may lead to neuronal degeneration in the developing rat brain

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F15622975.2011.647833

Revising a dogma: ketamine for patients with neurological injury?

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F15622975.2011.647833

No psychological emergence reactions in schizophrenic surgical patients immediately after propofol, fentanyl, and ketamine intravenous anesthesia

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F15622975.2011.647833

Thinking glutamatergically: changing concepts of schizophrenia based upon changing neurochemical models

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F15622975.2011.647833

The positive and negative syndrome scale (PANSS) for schizophrenia

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F15622975.2011.647833

The ictal EEG as a marker of adequate stimulus intensity with unilateral ECT

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F15622975.2011.647833

Long-term outcome of patients who receive ketamine during research

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F15622975.2011.647833

Effects of ketamine in normal and schizophrenic volunteers

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F15622975.2011.647833

mTOR-dependent synapse formation underlies the rapid antidepressant effects of NMDA antagonists

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F15622975.2011.647833

Augmentation strategies in electroconvulsive therapy

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F15622975.2011.647833

Cellular mechanisms underlying the antidepressant effects of ketamine: role of alpha-amino-3-hydroxy-5-methylisoxazole-4-propionic acid receptors

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F15622975.2011.647833

Ketamine-induced exacerbation of psychotic symptoms and cognitive impairment in neuroleptic-free schizophrenics.

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F15622975.2011.647833

Quantitative EEG during seizures induced by electroconvulsive therapy: relations to treatment modality and clinical features. I. Global analyses.

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F15622975.2011.647833

Glutamatergic dysfunction in catatonia? Successful treatment of three acute akinetic catatonic patients with the NMDA antagonist amantadine

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F15622975.2011.647833

Ketamine: an update on the first twenty-five years of clinical experience

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F15622975.2011.647833

Effectiveness of adding memantine to an Alzheimer dementia treatment regimen which already includes stable donepezil therapy: a critically appraised topic

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F15622975.2011.647833

Increased anterior cingulate cortical activity in response to fearful faces: a neurophysiological biomarker that predicts rapid antidepressant response to ketamine.

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F15622975.2011.647833

ECT anesthesia: the lighter the better?

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F15622975.2011.647833

Sympathomimetic effects of low-dose S(+)-ketamine. Effect of propofol dosage

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F15622975.2011.647833

Effect of ketamine on dendritic arbor development and survival of immature GABAergic neurons in vitro.

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F15622975.2011.647833

VEGF is an essential mediator of the neurogenic and behavioral actions of antidepressants

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F15622975.2011.647833

Survival after treatment of rabies with induction of coma

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F15622975.2011.647833

10.3109/15622975.2011.647833

21 January 2018

Identifiers

DOI

1 reference

9 February 2018

1 reference

9 February 2018